Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Waldencast plc (“Waldencast” or “the Company”) (NASDAQ: WALD, WALDW). Investors who purchased Waldencast securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/WALD.

Investigation Details:

On November 15, 2021, Waldencast issued a press release announcing entry into a business “into definitive simultaneous business combination agreements with leading science-based, results-driven skin care brand Obagi and award-winning makeup and skin care brand Milk Makeup.” Then, on July 5, 2023, Waldencast announced that certain of Obagi’s financial statements for periods prior to the merger transaction “should no longer be relied upon.” The financial statements containing errors and requiring restatement included those for 2021 and for the first quarter of 2022 and were included within Waldencast’s registration and proxy statement soliciting stockholder approval of the merger. On this news, Waldencast’s stock price fell $0.76 per share, or 10.2%, to close at $6.63 per share on July 6, 2023.

Then, on January 16, 2024, Waldencast reported its financial results for the fiscal year ended December 31, 2022, on Form 20-F, including restated financials for fiscal years 2020 and 2021. On this news, Waldencast’s stock price fell $1.57 per share, or 15.29%, to close at $8.70 per share on January 16, 2024.

On January 31, 2024, Waldencast announced the departure of its Chief Financial Officer and Chief Operating Officer, Philippe Gautier, effective immediately. On this news, Waldencast’s stock price fell $0.66 per share, or 9.36%, to close at $6.39 per share on February 1, 2024.

What’s Next?

If you are aware of any facts relating to this investigation or purchased Waldencast securities, you can assist this investigation by visiting the firm’s site: bgandg.com/WALD. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman:

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240226287500/en/